P. Martiat

Philadelphia-negative (Ph-) chronic myeloid leukemia (CML): comparison with Ph+ CML and chronic myelomonocytic leukemia. The Groupe Francais de Cytogenetique Hematologique

P. Martiat, Jl. Michaux, J Rodhain · Blood · 1991 · 118 citations · Full text

Medicine, Hematology, Oncology +13

Poor response to all-trans retinoic acid therapy in a t(11;17) PLZF/RAR alpha patient.

Fabien Guidez, Wenwen Huang, Jianhua Tong et al. · PubMed · 1994 · 81 citations

Medicine, Oncology, Oncogenes +6

BCR-ABL antisense oligodeoxyribonucleotides suppress the growth of leukemic and normal hematopoietic cells by a sequence-specific but nonantisense mechanism [see comments]

Jl. Vaerman, C. Lammineur, P Moureau et al. · Blood · 1995 · 61 citations

Medicine, Molecular Biology, Oncology +8

Retrovirally transduced antisense sequences stably suppress P210BCR-ABL expression and inhibit the proliferation of BCR/ABL-containing cell lines

P. Martiat, Philippe Lewalle, A. S. Taj et al. · Blood · 1993 · 54 citations · Full text

Medicine, Molecular Biology, Oncology +10

Infectious complications after 2‐chlorodeoxyadenosine therapy

Eric Van Den Neste, André Delannoy, A. Bosyl et al. · European Journal Of Haematology · 1996 · 46 citations

Medicine, Hematology, Oncology +15